To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?

LetterAçık Erişim

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/15642Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorAydin, Suleyman
dc.contributor.authorSahin, Ibrahim
dc.contributor.authorDemirel, Ulvi
dc.contributor.authorAksoy, Aziz
dc.date.accessioned2026-10-18T20:30:29.167157990Z
dc.date.available2026-10-18T20:30:29.167157990Z
dc.date.issued2011
dc.identifier.doi10.1016/j.metabol.2011.01.015
dc.identifier.issn1532-8600
dc.identifier.issue7
dc.identifier.pmid21397283
dc.identifier.scopus2-s2.0-79959357939
dc.identifier.startpageE1
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/15642
dc.identifier.volume60
dc.language.isoen
dc.relation.ispartofMetabolism: Clinical and Experimental
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectFatty Liver
dc.subjectGhrelin
dc.subjectHumans
dc.subjectIntercellular Signaling Peptides and Proteins
dc.subjectProtease Inhibitors
dc.subjectSerpins
dc.subjectamino acid
dc.subjectapelin
dc.subjectapelin 36
dc.subjectaprotinin
dc.subjectbenzylsulfonyl fluoride
dc.subjectcaspase
dc.subjectgamma glutamyltransferase
dc.subjectkallikrein inhibitor
dc.subjectobestatin
dc.subjectproteinase inhibitor
dc.subjectunclassified drug
dc.subjectvaspin
dc.subjectapoptosis
dc.subjectbiochemistry
dc.subjectblood analysis
dc.subjectdisease course
dc.subjectgamma glutamyl transferase blood level
dc.subjectgastrointestinal tract
dc.subjecthormone blood level
dc.subjecthuman
dc.subjectletter
dc.subjectliver cirrhosis
dc.subjectnonalcoholic fatty liver
dc.subjectpriority journal
dc.titleTo what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?
dc.typeLetter
dspace.entity.typePublication
rdl.citation.scopus2
rdl.source.indexSCOPUS